Literature DB >> 12925580

Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart.

Maria Sibilia1, Bettina Wagner, Astrid Hoebertz, Candace Elliott, Silvia Marino, Wolfram Jochum, Erwin F Wagner.   

Abstract

Mice lacking the epidermal growth factor receptor (EGFR) develop epithelial defects and a neurodegenerative disease and die within the first month of birth. By employing a conditional knock-in approach using the human EGFR cDNA mice humanised for EGFR (hEGFRKI/KI) were generated. Homozygous hEGFRKI/KI mice are viable and live up to six months. However, these mice are growth retarded and show skin and hair defects similar to Egfr-/- mutants. Interestingly, the neurodegeneration is fully rescued in hEGFRKI/KI mice, however, they develop a severe heart hypertrophy with semilunar valve abnormalities. Moreover, hEGFRKI/KI mice display accelerated chondrocyte and osteoblast differentiation, a phenotype that is also present in Egfr-/- mice and has not been previously described. The severity of the phenotypes correlates with the expression levels of the hEGFRKI allele, which is not efficiently expressed in epithelial and bone cells, but is expressed at similar and even higher levels as the endogenous Egfr in brain and heart. These results demonstrate that mice humanised for EGFR display tissue-specific hypomorphic phenotypes and describe a novel function for EGFR in bone development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12925580     DOI: 10.1242/dev.00664

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  48 in total

Review 1.  Valvulogenesis: the moving target.

Authors:  Jonathan T Butcher; Roger R Markwald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-08-29       Impact factor: 6.237

2.  Inhibition of ErbB2 by receptor tyrosine kinase inhibitors causes myofibrillar structural damage without cell death in adult rat cardiomyocytes.

Authors:  Laura Pentassuglia; Michael Graf; Heidi Lane; Yukio Kuramochi; Gregory Cote; Francesco Timolati; Douglas B Sawyer; Christian Zuppinger; Thomas M Suter
Journal:  Exp Cell Res       Date:  2009-02-12       Impact factor: 3.905

3.  D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR.

Authors:  Gabriele Eden; Marco Archinti; Ralitsa Arnaudova; Giuseppina Andreotti; Andrea Motta; Federico Furlan; Valentina Citro; Maria Vittoria Cubellis; Bernard Degryse
Journal:  Cell Mol Life Sci       Date:  2017-11-28       Impact factor: 9.261

4.  The critical role of the epidermal growth factor receptor in endochondral ossification.

Authors:  Xianrong Zhang; Valerie A Siclari; Shenghui Lan; Ji Zhu; Eiki Koyama; Holly L Dupuis; Motomi Enomoto-Iwamoto; Frank Beier; Ling Qin
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

Review 5.  The role of Neuregulin-1beta/ErbB signaling in the heart.

Authors:  Laura Pentassuglia; Douglas B Sawyer
Journal:  Exp Cell Res       Date:  2008-09-03       Impact factor: 3.905

6.  Increased differentiation capacity of bone marrow-derived mesenchymal stem cells in aquaporin-5 deficiency.

Authors:  Fei Yi; Muhammad Khan; Hongwen Gao; Feng Hao; Meiyan Sun; Lili Zhong; Changzheng Lu; Xuechao Feng; Tonghui Ma
Journal:  Stem Cells Dev       Date:  2012-04-20       Impact factor: 3.272

7.  iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling.

Authors:  Xue Li; Thorsten Maretzky; Gisela Weskamp; Sébastien Monette; Xiaoping Qing; Priya Darshinee A Issuree; Howard C Crawford; David R McIlwain; Tak W Mak; Jane E Salmon; Carl P Blobel
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

8.  Reduced EGFR causes abnormal valvular differentiation leading to calcific aortic stenosis and left ventricular hypertrophy in C57BL/6J but not 129S1/SvImJ mice.

Authors:  Cordelia J Barrick; Reade B Roberts; Mauricio Rojas; Nalini M Rajamannan; Carolyn B Suitt; Kevin D O'Brien; Susan S Smyth; David W Threadgill
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-15       Impact factor: 4.733

9.  Conditional inactivation of TACE by a Sox9 promoter leads to osteoporosis and increased granulopoiesis via dysregulation of IL-17 and G-CSF.

Authors:  Keisuke Horiuchi; Tokuhiro Kimura; Takeshi Miyamoto; Kana Miyamoto; Haruhiko Akiyama; Hironari Takaishi; Hideo Morioka; Takashi Nakamura; Yasunori Okada; Carl P Blobel; Yoshiaki Toyama
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

Review 10.  Epidermal growth factor signalling and bone metastasis.

Authors:  X Lu; Y Kang
Journal:  Br J Cancer       Date:  2009-12-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.